Trial site
Belvárosi Egészségház Kft.
- 11running trials
- 11closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Heart failure7 trials
- Atrial fibrillation4 trials
- Stroke3 trials
- Coronary artery disease2 trials
- Lupus (SLE)2 trials
- Obesity2 trials
- Alzheimer disease1 trial
- Chronic kidney disease1 trial
- Mild cognitive impairment1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 318 trials
- Phase 24 trials
- Status
- Completed11 trials
- Recruiting5 trials
- Active, not recruiting4 trials
- Not yet recruiting2 trials
- Lead sponsor
- Arrowhead Pharmaceuticals3 trials
- Novo Nordisk A/S3 trials
- Boehringer Ingelheim2 trials
- Janssen Research & Development, LLC2 trials
- Novartis Pharmaceuticals2 trials
- and 9 more
Running trials
Recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Recruiting
Recruiting
Active, not recruiting
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure4 recruiting
- Atrial fibrillation2 recruiting
- Lupus (SLE)1 recruiting
- Stroke1 recruiting
Closed trials
Active, not recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Completed
Completed
Study of Plozasiran in Adults With Severe Hypertriglyceridemia
Completed
Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Terminated
Completed
Completed
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026